Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Csl Behring Ag › Marc Nolte
MN

Marc Nolte — 14 Patents

CACsl Behring Ag: 13 patents #2 of 160Top 2%
CLCsl Limited: 7 patents #12 of 176Top 7%
UBUniversitat Bern: 2 patents #29 of 187Top 20%
JWJulius-Maximilians-Universitat Wurzburg: 1 patents #69 of 200Top 35%
The General Hospital: 1 patents #1,411 of 3,021Top 50%
WMWestfälische Wilhelms-Universität Münster: 1 patents #33 of 139Top 25%
Simmern, DE: #1 of 27 inventorsTop 4%
Overall (All Time): #332,869 of 4,157,543Top 9%
14 Patents All Time
Marc Nolte has been granted 14 US patents while listed as an inventor at Csl Behring Ag. The first was granted in 2016 and the most recent in August 2024. Marc Nolte ranks #332,869 of 4,157,543 US inventors in our database (top 8.0%). Patent records list Marc Nolte in Simmern, DE.

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDate
12065481 Therapy using a factor XII inhibitor in a neurotraumatic disorder Christoph Kleinschnitz, Anna-Leena SIRÉN, Christiane ALBERT-WEISSENBERGER, Sarah HOPP-KRAEMER 2024-08-20
11505619 Use of a FXIIa-inhibitor in the treatment of renal fibrosis and/or chronic kidney disease Malgorzata Wygrecka, Con Panousis 2022-11-22
11345759 Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodies Con Panousis, Veronika Rayzman, Andrew Donald Nash, Michael Wilson, Stefan Schmidbauer 2022-05-31
10973891 Treatment and prevention of remote ischemia-reperfusion injury Rolf SPIRIG, Sylvia Miescher, Claudia Duehrkop-Sisewitsch, Robert Rieben 2021-04-13
10513560 Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies Con Panousis, Veronika Rayzman, Andrew Donald Nash, Michael Wilson, Stefan Schmidbauer 2019-12-24
10286047 Treatment and prevention of remote ischemia-reperfusion injury Rolf SPIRIG, Sylvia Miescher, Claudia Duehrkop-Sisewitsch, Robert Rieben 2019-05-14
9987328 Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces Stefan Zeitler, Stefan Schulte, Gerhard Dickneite, Ingo Pragst 2018-06-05
9957329 Factor XII inhibitors for the treatment of neurological inflammatory disorders Sven Meuth, Kerstin Goebel, Christoph Kleinschnitz, Brent McKenzie 2018-05-01
9856325 Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal antibodies Con Panousis, Veronika Rayzman, Andrew Donald Nash, Michael Wilson, Stefan Schmidbauer 2018-01-02
9856326 Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies Con Panousis, Veronika Rayzman, Andrew Donald Nash, Michael Wilson, Stefan Schmidbauer 2018-01-02
9624307 Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs Matthias Nahrendorf, Ralph Weissleder, Gerhard Dickneite, Guido Stoll 2017-04-18
9518127 Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses Con Panousis, Veronika Rayzman, Andrew Donald Nash, Michael Wilson, Stefan Schmidbauer 2016-12-13
9452203 Use of C1-inhibitor for the treatment of secondary edema of the central nervous system Christoph Kleinschnitz, Guido Stoll, Gerhard Dickneite, Stefan Schulte, Bernhard Nieswandt +1 more 2016-09-27
9352016 Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces Stefan Zeitler, Stefan Schulte, Gerhard Dickneite, Ingo Pragst 2016-05-31

Nearby-Ranked Inventors

Ke PAN14
Naor Radami14
Jason Harris14
Gwangjae Jeon14
Masao Zen14
Yoshihiro YAMASAKI14
Sanjay Vakil14
Samuel Bartlett14
Taketoshi Okuno14